AI-generated summary
The authors studied stem cells from the apical papilla of immature third molars exposed to dental capping agents (MTA, Emdogain, CEM) and low-level laser therapy, alone and combined, in cell culture. They report that combining the capping agents with laser therapy was associated with higher cell viability than other groups, while MTA and CEM alone reduced survival. The study was conducted in cultured cells, which limits how far the findings apply to clinical use.
- Who or what was studied
- Stem cells from apical papilla (SCAPs) isolated from two immature third molar teeth, studied in cell culture
- Wavelengths
- 630 nm
- Limits stated in the abstract
- Laboratory cell culture study using cells from only two teeth, so results may not apply to living patients.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sbmu.ac.ir.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 630 nm
- Energy density (fluence)
- 4 J/cm2
- Power
- 5 mW
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.